Add to Basket
Order hotline:
![]() |
+1 404 474 4654 |
![]() |
+1 888 205 9894 (TF) |
Tumor Protein P73 (TP73) antibody
| Antigen | Tumor Protein P73 (TP73) |
| Synonyms | TP73, P73, Trp73, tp73, p73, Tp73, TAp73, zp73theta |
| Clonality | Monoclonal (5B429) |
| Host |
Alternatives Mouse |
| Reactivity |
Alternatives Human, Mouse (Murine) |
| Conjugate |
Alternatives Un-conjugated |
| Application |
Alternatives Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunocytochemistry (ICC), Immunofluorescence (IF), Immunoprecipitation (IP), Western Blotting (WB) |
![]() |
4 references available |
| Catalog no. | ABIN121331 |
| Quantity | 0.1 mg |
| Price | 352.00 $ Plus shipping costs $45.00 |
| Shipping to |
|
| Availability | Will be delivered in 6 to 8 Business Days |
Additional Information
| UniProt | O15350 |
| Immunogen | Full-length human p73 |
| Cross-Reactivity | Human, Mouse (Murine) |
| Isotype | IgG |
| Clone | 5B429 |
| Description | P73 was identified as a long-lost cousin of tumor suppressor protein, p53 (4). p73 has high homology with p53 as well as with p63, a gene implicated in the maintenance of epithelial stem cells. Significant homology between p53, p63, and p73 (approximately 63% amino acid identity in the DNA-binding domain suggest that they may have overlapping functions in the regulation of gene expression (3). The targeted disruption of p73 gene leads to defects hippocampal dysgenesis, hydrocephalus, chronic inflammation and infections (2). Recently, spilicing variant mRNAs of p73 has been identified in MCF-7, a breast carcinoma cell line. These mRNAs code for variant p73 proteins bearing distinct carboxy-terminal structures suggesting that the carboxy- terminal region of p73 may be important for the functions of this protein (1). Tumor BioMarker: Vella et al (2003) found p73 to be upregulated in a significant fraction of anaplastic thyroid cancers, whereas it was not detectable in normal thyroid epithelial cells nor in papillary or follicular thyroid cancer. |
Application Details
| Application Notes | Western blot analysis: 2 ug/ml. Immunoprecipitation: Please see Sayan et al (2005) for details. Immunofluorescence/Immunocytochemistry: Please see Vella et al (2003) and Sayan et al (2005) for details. IHC (frozen): See Dominguez et al (2006) for details. Recommended positive control: p73 transfected cells. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user. |
| Purification | Purified |
| Buffer | PBS containing 0.05 % BSA and 0.05 % sodium azide |
| Storage | Store the antibody (in aliquots) at -20 °C. Can be shipped at 2 - 8 °C. Avoid repeated freezing and thawing. Centrifuge vial before opening. Shelf Life: One year from despatch. |
| Restrictions | For Research Use only |
Images
| Western blot analysis of p73 in A) transfected cell lysate and B) HeLa cell lysate using ABIN121331 at 2 |
Publications
|
Kaghad, Bonnet, Yang et al.: "Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers." in: Cell, Vol. 90, Issue 4, pp. 809-19, 1997 (PubMed).
Yang, Walker, Bronson et al.: "p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours." in: Nature, Vol. 404, Issue 6773, pp. 99-103, 2000 (PubMed). Levrero, De Laurenzi, Costanzo et al.: "The p53/p63/p73 family of transcription factors: overlapping and distinct functions." in: Journal of cell science, Vol. 113 ( Pt 10), pp. 1661-70, 2000 (PubMed). Minagawa, Honda, Miyazaki et al.: "Comparative proteomic and transcriptomic profiling of the human hepatocellular carcinoma." in: Biochemical and biophysical research communications, Vol. 366, Issue 1, pp. 186-92, 2007 (PubMed). |
|
Alternatives
Alternatives for antigen "Tumor Protein P73 (TP73)", type "Antibodies"




Alternatives